telmisartan has been researched along with Coronary Artery Disease in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (33.33) | 29.6817 |
| 2010's | 11 (61.11) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Agrawal, S; Anand, J; Bachani, D; Doshi, M; Gaikwad, VB; Halder, SK; Kinholkar, B; Kumar, DA; Kumbhar, A; Mathur, R; Mehta, S; Sarkar, G; Sharma, A | 1 |
| Achenbach, S; Cicha, I; Garlichs, CD; Klinghammer, L; Lewczuk, P; Raaz-Schrauder, D; Urschel, K | 1 |
| Ise, T; Iwase, T; Kusunose, K; Niki, T; Oeduka, H; Sata, M; Soeki, T; Taketani, Y; Wakatsuki, T; Yamada, H; Yamaguchi, K | 1 |
| Böhm, M; Foulquier, S; Schmieder, R; Schumacher, H; Sleight, P; Teo, K; Unger, T; Yusuf, S | 1 |
| Lackland, DT | 1 |
| Angeli, F; Gao, P; Mancia, G; Pogue, J; Reboldi, G; Sleight, P; Teo, K; Trimarco, B; Verdecchia, P; Yusuf, S | 1 |
| Chen, CH; Cheng, HM; Hoshide, S; Huang, QF; Kario, K; Park, CG; Park, S; Wang, JG | 1 |
| Avezum, A; Cardona-Munoz, E; Dagenais, GR; Diaz, R; Dyal, L; Fodor, G; Maillon, JM; Mann, JF; McQueen, MJ; Pogue, J; Probstfield, JL; Rydén, L; Schmieder, RE; Schumacher, H; Teo, KK; Wang, X; Yu, CM; Yusuf, S | 1 |
| Itoh, T; Minami, Y; Nakamura, M; Satoh, M; Tabuchi, T; Takahashi, Y | 2 |
| Cianfrocca, C; Gaudio, C; Mercuro, G; Pasceri, V; Pelliccia, F; Rosano, GM; Speciale, G; Vitale, C | 1 |
| Haraguchi, G; Ishihara, T; Isobe, M; Kosuge, H; Maejima, Y; Okada, H; Saiki, H; Suzuki, J | 1 |
| Akaike, M; Bando, S; Hirata, Y; Iwase, T; Koshiba, K; Kusunose, K; Niki, T; Sata, M; Soeki, T; Taketani, Y; Tomita, N; Wakatsuki, T; Yagi, S; Yamada, H; Yamaguchi, K | 1 |
| Arfa, O; Czech, T; Ebrahimian, T; Endtmann, C; Fritz, M; Laufs, U; Nickenig, G; Petoumenos, V; Wassmann, K; Wassmann, S; Werner, N | 1 |
| Imaizumi, T; Jinnouchi, Y; Matsui, T; Nakamura, K; Nakamura, Y; Takenaka, K; Yamagishi, S | 1 |
| Kurtz, TW | 1 |
2 review(s) available for telmisartan and Coronary Artery Disease
| Article | Year |
|---|---|
Target Blood Pressure in Patients with Diabetes: Asian Perspective.
Topics: Aged; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Hypotension; Male; Middle Aged; Ramipril; Randomized Controlled Trials as Topic; Reference Values; Risk Factors; Stroke; Telmisartan | 2016 |
New treatment strategies for patients with hypertension and insulin resistance.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Atherosclerosis; Benzimidazoles; Benzoates; Coronary Artery Disease; Diabetes Mellitus, Type 2; Humans; Hypertension; Insulin Resistance; Metabolic Syndrome; PPAR gamma; Renin-Angiotensin System; Telmisartan | 2006 |
9 trial(s) available for telmisartan and Coronary Artery Disease
| Article | Year |
|---|---|
Fixed-dose Combination of Metoprolol, Telmisartan, and Chlorthalidone for Essential Hypertension in Adults with Stable Coronary Artery Disease: Phase III Study.
Topics: Adult; Amlodipine; Antihypertensive Agents; Blood Pressure; Chlorthalidone; Coronary Artery Disease; Drug Therapy, Combination; Essential Hypertension; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Metoprolol; Telmisartan; Tetrazoles | 2022 |
Effects of telmisartan on inflammatory cytokines and coronary plaque component as assessed on integrated backscatter intravascular ultrasound in hypertensive patients.
Topics: Antihypertensive Agents; Benzimidazoles; Benzoates; Coronary Artery Disease; Cytokines; Female; Follow-Up Studies; Humans; Hypertension; Inflammation Mediators; Male; Plaque, Atherosclerotic; Telmisartan; Ultrasonography, Interventional | 2014 |
Impact of telmisartan on cardiovascular outcome in hypertensive patients at high risk: a Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease subanalysis.
Topics: Aged; Antihypertensive Agents; Benzimidazoles; Benzoates; Cardiovascular Diseases; Cardiovascular System; Coronary Artery Disease; Female; Follow-Up Studies; Heart Failure; Hospitalization; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Myocardial Infarction; Peripheral Vascular Diseases; Stroke; Telmisartan; Treatment Outcome | 2014 |
Systolic and diastolic blood pressure changes in relation with myocardial infarction and stroke in patients with coronary artery disease.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Coronary Artery Disease; Diastole; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Myocardial Infarction; Ramipril; Stroke; Systole; Telmisartan; Time Factors; Treatment Outcome | 2015 |
Effect of telmisartan on renal outcomes: a randomized trial.
Topics: Aged; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Coronary Artery Disease; Creatinine; Diabetic Nephropathies; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Kidney Diseases; Male; Middle Aged; Risk Factors; Telmisartan | 2009 |
Prospective, randomized, single-blind comparison of effects of 6 months of treatment with telmisartan versus enalapril on high-molecular-weight adiponectin concentrations in patients with coronary artery disease.
Topics: Adiponectin; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; C-Reactive Protein; Coronary Angiography; Coronary Artery Disease; Double-Blind Method; Enalapril; Female; Follow-Up Studies; Humans; Insulin Resistance; Male; Molecular Weight; Prospective Studies; Telmisartan | 2009 |
Angiotensin II receptor antagonism with telmisartan increases number of endothelial progenitor cells in normotensive patients with coronary artery disease: a randomized, double-blind, placebo-controlled study.
Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Brachial Artery; Coronary Artery Disease; Double-Blind Method; Endothelium, Vascular; Female; Humans; Hypertension; Male; Middle Aged; Placebos; Prospective Studies; Receptors, Angiotensin; Stem Cells; Telmisartan | 2010 |
Expression of miR-146a/b is associated with the Toll-like receptor 4 signal in coronary artery disease: effect of renin-angiotensin system blockade and statins on miRNA-146a/b and Toll-like receptor 4 levels.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Atorvastatin; Benzimidazoles; Benzoates; Cells, Cultured; Coronary Artery Disease; Drug Therapy, Combination; Enalapril; Female; Follow-Up Studies; Gene Expression Regulation; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; MicroRNAs; Middle Aged; Pyrroles; Renin-Angiotensin System; Signal Transduction; Single-Blind Method; Telmisartan; Toll-Like Receptor 4 | 2010 |
Angiotensin II impairs endothelial progenitor cell number and function in vitro and in vivo: implications for vascular regeneration.
Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Apolipoproteins E; Apoptosis; Benzimidazoles; Benzoates; Blood Vessels; Bone Marrow Transplantation; Cell Count; Cells, Cultured; Coronary Artery Disease; Double-Blind Method; Endothelial Cells; Female; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Ramipril; Receptor, Angiotensin, Type 1; Regeneration; Stem Cells; Telmisartan; Vasoconstrictor Agents | 2011 |
7 other study(ies) available for telmisartan and Coronary Artery Disease
| Article | Year |
|---|---|
Impact of telmisartan on the inflammatory state in patients with coronary atherosclerosis--influence on IP-10, TNF-α and MCP-1.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Atherosclerosis; Benzimidazoles; Benzoates; Blood Pressure; Chemokine CCL2; Chemokine CXCL10; Coronary Artery Disease; Female; Humans; Hypertension; Inflammation; Interleukin-6; Male; Middle Aged; Telmisartan; Tumor Necrosis Factor-alpha | 2013 |
Systolic blood pressure target levels: evidence for benefits in stroke.
Topics: Benzimidazoles; Benzoates; Blood Pressure; Coronary Artery Disease; Female; Humans; Male; Myocardial Infarction; Ramipril; Stroke; Telmisartan | 2015 |
Telmisartan did not prevent renal disease in patients without proteinuria.
Topics: Aged; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Coronary Artery Disease; Creatinine; Diabetic Nephropathies; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Kidney Diseases; Male; Middle Aged; Risk Factors; Telmisartan | 2009 |
Treatment with telmisartan attenuates graft arteriosclerosis in murine cardiac allografts.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Cell Division; Coronary Artery Disease; Cytokines; Graft Rejection; Heart Transplantation; Hyperplasia; Male; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Muscle, Smooth, Vascular; PPAR gamma; Telmisartan; Transplantation, Homologous; Tunica Media | 2010 |
Elevated concentrations of pentraxin 3 are associated with coronary plaque vulnerability.
Topics: Aged; Angina Pectoris; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Biomarkers; C-Reactive Protein; Coronary Artery Disease; Coronary Sinus; Disease Progression; Drug Monitoring; Female; Humans; Inflammation Mediators; Male; Middle Aged; Plaque, Atherosclerotic; Serum Amyloid P-Component; Severity of Illness Index; Telmisartan; Tomography, Spiral Computed | 2011 |
Telmisartan inhibits expression of a receptor for advanced glycation end products (RAGE) in angiotensin-II-exposed endothelial cells and decreases serum levels of soluble RAGE in patients with essential hypertension.
Topics: Administration, Oral; Age Factors; Aged; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Antioxidants; Benzimidazoles; Benzoates; Blotting, Western; Coronary Artery Disease; Disease Progression; DNA Primers; Endothelial Cells; Endothelium, Vascular; Female; Humans; Hypertension; Male; Microcirculation; Middle Aged; Oxidative Stress; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Telmisartan; Time Factors; Up-Regulation | 2005 |
[Preventing cardiovascular diseases. Discovering the optimal approach].
Topics: Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Coronary Artery Disease; Coronary Vessels; Drug Therapy, Combination; Humans; Ramipril; Randomized Controlled Trials as Topic; Telmisartan | 2001 |